ebook img

Journal of Psychopharmacology 2003: Vol 17 Index PDF

9 Pages·2003·1.4 MB·English
by  
Save to my drive
Quick download
Download
Most books are stored in the elastic cloud where traffic is expensive. For this reason, we have a limit on daily download.

Preview Journal of Psychopharmacology 2003: Vol 17 Index

Psychopharm Subject Index Journal of Psychopharmacology 18(1) (2004) 136-139 Volume 17 2003 © 2004 British Association for Psychopharmacology ISSN 0269-8811 SAGE Publications Ltd, London, Thousand Oaks, CA and New Delhi 10.1177/0269881104042254 Abstracts not included Anxiety — anxiogenic-like effect of CRF2 antisense oligonucleotides infused Acamprosate into rat brain 409 — to reduce drinking and aid abstinence 397 — induced by simulated public speaking 184 Acoustic startle response (ASR) — quitting ecstasy and subsequent mental health 371 — effects of procyclidine on PPI of the ASR in schizophrenia 89 Arousal Addiction — dissociation effects of triazolam-amphetamine — controversies over the SSRIs interaction 17 Adrenoceptor Attention deficit hyperactivity disorder (ADHD) — mechanisms underlying imipramine-induced memory deficits in — antidepressant treatment in adults 332 rats 83 — lofexidine in the treatment of children with 113 Aggression — in patient with temporal lobe epilepsy 350 Barnes Akathisia Rating Scale — quitting ecstasy and subsequent mental health 371 ~ revisited (review) 365 Akathisia Binocular depth inversion — Barnes rating scale 365 — effects of (S)-ketamine inman 51 — fluoxetine dose-increment related 451 Bipolar disorder Alcohol — consensus on the treatment of — 147, 149 — acamprosate to reduce drinking and aid abstinence 397 — levetiracetam in rapid cycling 239 — correlation of hyperforin and alcohol drinking in CS7BL/6J mice — menstrual cycle effects on hypothalamic dopamine receptor 403 function in 204 — effects on psychomotor and attentional performance 379 — pharmacological treatment of 230 — lorazepam during extinction of self-administration in rats 293 Amphetamine Caffeine — increases aversive conditioning at higher footshock intensity 67 — and clonidine effects on mood, performance and cardiovascular — interaction with triazolam = 17 measures 283 Anticholinergics Cannabis — patterns of prescribing in hospital inpatients 223 — chronic abuse raises nerve growth factor in schizophrenic patients Anticonvulsants 439 — in the treatment of bipolar disorder 149, 230, 239 Carbamazepine Antidepressants — psychomotor effects in epileptic patients and volunteers 269 — inthe treatment of ADHD 332 Carbon dioxide (CO,) — in the treatment of bipolar disorder 149, 230 — CO, challenge and the brain noradrenaline network 252 — REM sleep as a biomarker for the effects of in healthy volunteers Clonazepam 196 — combination with paroxetine in panic disorder 276 — thyroid hormones 431 Clonidine Antipsychotics — and caffeine effects on mood, performance and cardiovascular — assessment of treatment outcome using the Routine Assessment of measures 283 Patient Progress 425 Clozapine Barnes akathisia rating scale 365 — clinical utility of serum levels 234 in the treatment of bipolar disorder 149, 230 Cognitive behaviour therapy (CBT) patterns of prescribing in hospital inpatients 223 — inthe treatment of bipolar disorder 149 prolongation of QTc interval treated with magnesium 346 Cognitive deficits reduced bone mineral density in patients with schizophrenia — phencycline- induced improved by ziprasidone but not haloperidol receiving prolactin raising antipsychotic medication 455 in rats 57 Antisense Cognitive performance — anxiogenic-like effect of CRF2 antisense oligonucleotides infused — effect of acute tryptophan depletion 300 into rat brain 409 — effects of caffeine and clonidine 283 Subject Index 137 Conditioning GABA-ergic drugs — amphetamine increases aversive to diffuse contextual stimuli and — inaffective disorders 174 discrete trace stimulus 67 Gabapentin — ethanol disrupts fear conditioning in mice 77 — effect on anxiety induced by simulated public speaking 184 Corticotropin-releasing factor (CRF) Gambling — anxiogenic-like effect of CRF2 antisense oligonucleotides infused — effect of tryptophan depletion on probabilistic choice 3 into rat brain 409 Guidelines Cortisol — for treating bipolar disorder 149 — increased by acute reboxetine administration in volunteers 273 Huntington’s disease — effects of baseline on the prolactin response to fenfluramine in — case reports of ziprasidone treatment 459 depression 97 — why minocycline is helpful 461 Hyperforin Dependence — correlation of content with effects on alcohol drinking in — controversies over the SSRIs 355 CS7BL/6J mice 403 Depersonalization disorder Hypericum perforatum (St John’s Wort) — aplacebo-controlled, crossover trial of lamotrigine in 103 — correlation of hyperforin content with effects on alcohol drinking Depression in CS7BL/6J mice 403 — current therapy and future treatment strategies 337 Imipramine — effect of quetiapine in schizophrenia 210 — memory deficits in rats and adrenoceptor mechanisms 83 — prolactin response to fenfluramine: effects of melancholia and Immune function cortisol 97 — effects of emotional stress in rats 179 — quitting ecstasy and subsequent mental health 371 — sertraline for depressive symptoms in patients with stable chronic Ketamine schizophrenia 107 — effects of S-enantiomer on psychopathology and binocular depth Discontinuation syndrome inversion inman 51 — associated with nefazodone 447 — controversies over the SSRIs 355 Lamotrigine Dopamine — in depersonalization disorder; a placebo-controlled cross over trial — effects of D, and D, receptor function on object working memory 103 inhumans 9 Levetiracetam — involvement of receptors of the dorsal hippocampus on the — in rapid cycling bipolar disorder 239 acquisition and expression of morphine-induced place preference Lofexidine inrat 415 — to treat children with tic disorders and ADHD 113 — menstrual cycle effects on dopamine receptor function in women Lorazepam with a history of puerperal bipolar disorder 204 — and alcohol during extinction of self-administration in rats 293 Driving — dissociation of visual and auditory event-related potentials 31 — residual effects of zopiclone, zolpiden and flunitrazepam in simulated task 324 Magnesium — antipsychotic-induced prolongation of QTc interval treated with Ecstasy - see MDMA 346 Emotional stress MDMA — effect of on primary humoral immunity of rats 179 — effects of a single dose of psychomotor and attentional Epileptic patients performance 379 — psychomotor effects of carbamazepine 269 neurocognitive deficits associated with 242 Ethanol neuropsychiatric consequences of use 342 — comparison with temazepam on performance testing 41 self-report patterns of drug use and memory ability 389 — disrupts fear conditioning in C57BL/6 mice 77 why people stop taking the drug and subsequent mental health Event-related potentials 371 — effects of lorazepam and flunitrazepam 31 Memory Evidence-based guidelines — deficits induced by: imipramine and adrenoceptor mechanisms — for treating bipolar disorder 149 83 — dissociation effects of triazolam-amphetamine interaction 17 Fenfluramine (d-fenfluramine) — self-reports of memory ability and drug use 389 — prolactin response in depression 97 Minocycline — prolactin response in personality disorder 216 — in Huntington’s disease 461 Flunitrazepam Mirtazepine — residual effects on simulated task of collision anticipation — pharmacovigilance of 121 Fluoxetine Mood stabilisers — and thyroid hormones in major depression 431 — inthe treatment of bipolar disorder 149, 230 — dose-related akathisia 451 138 Subject Index Nefazodone Quetiapine — discontinuation symptoms 447 — differential effect on depression in schizophrenia 210 Nerve growth factor — raised by chronic cannabis abuse in schizophrenic patients 439 Reboxetine Neuroendocrine — acute administration increases cortisol in healthy volunteers 273 — menstrual cycle effects in women with a history of puerperal — promotes social bonding in healthy volunteers 189 bipolar disorder 204 REM sleep Neuropsychological function — as a biomarker for the effects of antidepressants in healthy — effect of acute tryptophan depletion 300 volunteers 196 Noradrenaline Reversal learning — and the effects of the CO2 challenge 252 — ziprasidone but not haloperidol improves phencyclidine-induced — effects of caffeine and clonidine on mood, performance and cognitive deficits in the rat 57 cardiovascular measures 283 Risperidone Nortriptyline — blepharospasm in a patient with schizophrenia 453 — and thyroid hormones in major depression 431 Schizophrenia Obsessive-compulsive disorder (OCD) — chronic cannabis abuse raises nerve growth factor in drug-naive — skin-picking behaviour after SSRI treatment 127 patients 439 Olanzapine effects of acute metabolic stress on the peripheral vasopressinergic — for recurrent aggression in epilepsy 350 system 317 effects of procyclidine on the PPI of the ASR 89 Panic disorder quetiapine on depressive symptoms 210 — combined paroxetine and clonazepam treatment strategy 276 reduced bone mineral density in patients receiving prolactin Paroxetine raising medication 455 — combination with clonazepam in panic disorder 276 risperidone rechallenge after blepharospasm 453 Performance testing sertraline for depressive symptoms in patients with stable chronic — acomparison of ethanol and temazepam 41 107 Personality disorder Self-administration — prolactin response to d-fenfluramine 216 — effects of alcohol and lorazepam in rats 293 Phencyclidine Selective serotonin reuptake inhibitors (SSRIs) — induced cognitive deficits improved by ziprasidone but not — current controversies 355 haloperidol in rats 57 — skin-picking behaviour in patients withOCD 127 Prepulse inhibition (PPI) Sertraline — effects of acute procyclidine administration on PPI of the ASR in — for depressive symptoms in patients with schizophrenia 107 schizophrenia 89 Simulated public speaking Prescribing practice — effects of gabapentin on anxiety induced by 184 — patterns of antipsychotic and anticholinergic prescribing for Sleep hospital inpatients 223 — REM sleep effects as a biomarker for the effects of antidepressants Prescription event monitoring in healthy volunteers 196 — pharmacovigilance of mirtazepine 121 Smoking Procyclidine — selective processing of smoking-related cues on the modified — effects of on the PPI of the ASR in schizophrenia 89 Stroop task 310 Prolactin Social behaviour — reduced bone mineral density in patients with schizophrenia — reboxetine in healthy volunteers 189 receiving antipsychotic medication 455 Stress — response to fenfluramine in depression 97 — effects of metabolic stress on the peripheral vasopressinergic Psychomotor measures system in schizophrenia 317 — effects of caffeine and clonidine 283 Stroop task — effects of carbamazepine in epileptic patients and — selective processing of smoking-related cues 310 volunteers 269 — effects of a single dose of ecstasy 379 Temazepam Psychopathology — comparison with ethanol on performance testing 41 — effects of (S)-ketamine inman 51 Thyroid hormones Psychopathy — response to fluoxetine and nortriptyline in major depression 431 — screening version of the checklist and relationship to serotonergic Treatment outcome function 216 — outcome measured in pharmacological trials using the Routine Puerperal Assessment of Patient Progress 425 — bipolar disorder 204 Triazolam — interaction with amphetamine 17 QTc interval Tryptophan depletion — antipsychotic-induced prolongation of 346 — effect on neuropsychological function 300 Subject Index 139 Tryptophan depletion continued Ziprasidone — effect on probabilistic choice 3 — improves phencyclidine-induced cognitive deficits in rats — in Huntington’s disease 459 Vasopressin Zolpidem — effects of acute metabolic stress in schizophrenia 317 — dependence 131 — residual effects on simulated task of collision anticipation Withdrawal Zopiclone — controversies over the SSRIs 355 — residual effects on simulated task of collision anticipation Working memory — effects of D, and D, receptor function in humans 9 Psychopharm Author Index Journal of Psychopharmacology 18(1) (2004) 140-143 Volume 17 2003 © 2004 British Association for Psychopharmacology ISSN 0269-8811 SAGE Publications Ltd, London, Thousand Oaks, (A = Abstracts, first author only; S = Supplement) CA and New Delhi 10.1177/0269881104042253 Abdel-tawab AM AI4 Brice C 283 Abdul-Monim Z 57, A46 Brown N= 204 Abel K A9 Bryan-LlukaLJ A80 AdlerC 317 Buckley P 210 Ahmed FP A29 Bueno OFA 31 AlfordC A61 BuisC A25 Alhaj HA A65 Bull EJ A35 AllisonC A31 BullmoreE A4 AlmeidaE 350 Burnham KE A71,A78 AndersonIM 3, 216, Al Bushe C A20, A49, A53 Anderson NJ A39 BusnelloJV 184 Andreasan JT A45 AntonovaE A43 Cadzow AL All Argyropoulos SV 252, 267 CahirM A46, A48 Ashley PJ A20 CaldirolaD 263 Ashton H_ 174 Cambridge NJ. A74 Ashurst EJ A63 Campbell LC 204 Attenburrow MJ Al6 CashD A37 Cassaday HJ 67 Badawy AAB_ A30 Castle DJ 234 Bailey JE 252, 267 Cerri KH AS51 BarichelloR 184 Checkley SA 204 Barkatakil A51 CiliaJ A44 Barnes TRE A54 Clark L 245 Bartholomeusz CF 9 Clark L A36,A70 BatesonAN AS Clarke HF A69 BellR A30 Cluderay JC A38 BellodiL 263 Coghill DR A74,A77 BennettS A40 Cohen AF 196, 269 Benz MA_ A35 CoolsR A57 BertaniA 263 Cooper SJ. 107 BerthelonC 324 Cowen PJ 273 BhagwagarZ A14,A17 Cox SML_ A811 Bianchi M A18,A78 Craig M A58, A59, A77 Biswas PN_ 121 Craighead MW A19 Blackwell AD A55 Crippa JAS 350 Bocca ML 324 Cropley A48 BodyS A69 CurranHV A26 Bond AJ 189 Cutter WJ A59 Borsutzky M_ 51 Boston PF A56 Dakin HA A54 BoxG 9 Dalley JW AS55 Braddick FMB A34 DasM 89 Bradley BP 310 David AS 103 BradleyS A74 DaviesRA 204 Bradshaw CM 3, A69 Davies SIC A42 BreierA 317 Davies W A70 BrettRR A32 De Deyn PP A57 Author Index de Visser SJ 196 GuarnieriR 350 DeakinIH AS51 Deakin JFW 350 Hallak JEC 350 Del-BenCM A12,A15,A25, A79 Hallak JEC A55, A80 DelvaiNA A14 HampsonE A9 Denise P 324 Hampson M A110 DenysD 127 HarkinA A34 de-Paris F 184 Harmer CJ 273, Al Derberdt W A57 Harper LK A40 Dolan MC 216 Harrington M = 223 Doyle AL 276 HarrisonCL 230 Drevets WC A4 Harrison PJ A8 DrummondG 41 Hartley DE A62 DuffettR 223 Hartz BP A28 DukaT 293 HaslerF A44,A76 DukaT A9 HealyD A21,A53 Dursun SM 350 Helms CM A70 HeskethSA A15 Edgar CJ A60, A68 Hewitt KN A74,A77 ElandsCM_ A113 HeydariA A36 EllisKA A66 Hill SA = 273 Elman! 317 HirozJ 41 ElsabaghS A6l Hirst AD 204 Emrich HM _ 51 HoMY A66 Emsley RA 210 HolmesL 41 Ettinger U ASO HomayounH 83 Evoniuk G A22 Honer WG AS56 Horlsley R A66 Fairchild CF A17,A76 HoshiR A33 FeldonJ A45 HowesO AS53 Fell MJ A52 HsuFC AI18 Ferre C 352 Hughes JH 300 Ferrie LJ. A22, A80 Ferrier IN 230 Idle T A32 Finn DP A32 Idris NF A69 Fletcher PV A4 ImranN 346 Fox HC 242 Inkster B A75 FranklinM A13 Ishii Y A75 Franson KL 196 Isles AR A26 Issac MB ASO Galdur6z JCF 31 IvinG 103 GaleaA 89 Izquierdo! 184 Gallagher P 300 GandhiP A13,A21 Jackson A 293, A28 GaravanH A4 Jones AM 210 Genn RF A27 Jones DNC A52 GhiasvandM_ 83 Jones HC 89 GiakoumakiSG A45 Jones PB A8 Goetghebeur P A26 Josolyne SE A33 Goford J A62 Joyce PR 97 Goldberg SR A33 Golembo N A43 Kalinishev M_ A81 GoodwinGM_ 149, SI Kane JM ASO Gorman JM 265 KapezinskiF 184 Gould TJ 77 KapurS A8 Grasby PM A7 KarstM 51 Greenwood MR 210 KellyCB A110 Greenwood-Smith C 234 Kelly TP 300 Griez E 260 Kennedy DO A60 Griffiths RR 17 KerwinR A2 Groves JO <A43 KhavandgarS 83 142 Author Index KheraminS A66 Mosimann UP A58 Khundakar AA Al3 Muggleton NG A65 KillcrossS A6 Mulder RT 97 KimuraA A38 Mulholland C107 King DJ 107 Miller U A67 King MV A65 Munafb M_ 310 Knowles SK A63 Murphy M_ 310 KrhgerS 239 Murthy NV A55 Kroon JM 269 Krystal J 103 NaderK A6 Krystal JH A7 Nally R A75 Kumar RC 204 NamjoshiM AS50 Kumari V_ 89, A42, A43 NashJ 283 Nash JR A30 Lambourne SL A58 Nathan PJ 9 Law AJ A38, A47 NeiderhoferH 113 Lawrence K A52 Neill JC 57 Lelliott P 223 NesicJ A26 LendonC A9 Nicol AU A6 Lenox-SmithA A10,A12 Norbury R A56 Lightman SL 252, 267 Norman C 67, A67 Lignum F A37 Nutt DJ = 147, 251, 252, 267, 283, A3 LinW_ 179 Littleton JM A3 O’Neill M A40, A72 Lloyd AJ 230 O’SullivanGJ A26 Lubman DI 234 Odontiadis J A116 LukasS 317 Okoche C223 LynchG_ 107 Otto MW 276 Lythe KE A67 Overbury AL A32 OwenLA A42 Maidment ID 332 OwenM A8 MairA 113 Malik N A24 PalazidouE A22 MaliziaA AS5 Papadopoulos A 204 Malykhin N A23 Parrott AC 242, A34 Manktelow TC AS59, A64, A75 PaskaW A24 ManzanoGM 31 PassieT 51 Marks MN) 204 PatersonLM A39 MarshallI A60,A64 Paterson NE A3l1 MartinIL A3 Patil PR A29 Martin MT A76 PatonC 223 MathiasenLS A29 Pemberton DJ A46 Matthews D 300 Peters P 276 MaycockS A28 Phillips ML 103 Mayers AG A27 PiccoliL A41 McAllister-Williams RH S7 Pickles AR A19 McGee D_ A22, A23 Pieters MSM 269 McQuadeR AI8 Pollack MH 276 MehrotraR 89 PompéiaS 31 Mehta MA _ A25, A67, A79 Porter RJ 97 Milstein JA A71 Postma P <A45 Mintzer MZ 17 Pottier A 324 Mirza NR A30 PouzetB A46 Mitchell A 245 PryceCR A19,A76 Mitchell SH A36 ModestinJ 342 QuevedoJ 184 Mogg K 310 Moore NA_ A48, A49 RampesH 346 Moran PM A42, A79 Randall DC A70 Moret C 337 Redrobe JP A72 Morgan CJA A36, A68 ReidIC Al Author Index Reynolds DS. AS TaylorD 89 Reynolds GP 57, A2 TaylorD A53,A56 Rezeck K 350 Taylor MJ 273 Rhodes SM <A73 Thase ME Al,AII RichN 283 Theunissen EL A63 Richell RA 3 TiillieD Al6 Rijnbeek E 196 Tiplady B41 Roberts S 310 Tiplady B A71,A72, A73 Robertson DA A118, A78 TomkinsonS A68 Robinson ESJ A39 Toshkov F 276 Rodgers J A68 TraceyI A7 Rodgers RJ. A28 TroakesC AI5 Roe CH <A37 Tse WS 189 Roiser JP A34 Tspakis EM A81 Rosa MLNM_ A44 TucciS A25 RosenS 346 TuckerGT A2 RostamiP 83 TufikS 31 Rostami-Hodjegan A A37, A54 Turnbridge EM A49,A79 RottD 317 Turner DC A71,A78 RourkeA 48 Tyacke RJ. A39 Ruldolph U- A5 TzivelekisS ASI Sakamoto AC 350 van Gerven JMA_ 196, 269 Sant’Anna MK _ 184 Van KalkerenJ A41 SawyerP All van Megen HJGM_ 127 Saxby BK A65 Van RooyC 9 Scaife JC A27 van Steveninck AF 269 Scheel-KriigerJ All Vasudev A21 Schneider U_ 51 VecellioM 342 Schoemaker RC 269 VennH A20 Scholey AB A61, A62 Verster JC A38 SchopperC 342 Vianna MRM_ 184 ScottSD A62 Vollum B A112, A73 ScullionGA A31 Sensky T 223 Wang W_ 179 Serretti A A2 Washington WC Jr_ 179 ShafaghiB 83 WatsonS S7 Shakir SAW 121 Wesnes K A58, A63 ShaoF 179 Westenberg HGM = 127 Sharma T 89, A44, A77 Wieck A 204 Shoaf SE 317 Wiese B51 Shufflebotham J A17 Williams SCR A6 SierraM 103 Wilson SJ. A73 Simon NM_ 276 Wilton LV 121 SinghAN- A15, A24, A47 Winstanley CA A64 SloughS A10 Witchel HJ A29 SmithA 283 Woodman M AI19 Smith DJ A21 Worthington JJ 276 SoarK A35 Sokoloff P A2 Young AH_= 174, 230, 300, A23, S7 Solowij N A54, A80 Young JW A64 SpinelliS A60 Squires SM A72, A81 Zachariah E 89 StaffenW 113 Zarrindast MR_ 83 Staufenberg EFA AS5S9 Zhang ZZ A41 Stephens DN 293 Zheng L_ 179 StewardCA A41I Zuardi AW 350 Stewart ME 300 Stolerman IP A31 Stone JM A49

See more

The list of books you might like

Most books are stored in the elastic cloud where traffic is expensive. For this reason, we have a limit on daily download.